☆ 4.6 Article

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer

CANCERS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer

Yanan Duan et al.

Summary: This study retrospectively collected clinical data of patients with synchronous or metachronous OMEC and assessed the safety and efficacy of concurrent or sequential treatment with radiotherapy plus PD-1 inhibitors. The results showed that this treatment option is safe and effective for patients with OMEC.

CANCER MANAGEMENT AND RESEARCH (2023)

添加到收藏夹

Article Oncology

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

Tiuri E. Kroese et al.

Summary: This study aimed to develop a multidisciplinary European consensus statement on the definition, diagnosis and treatment of oligometastatic oesophago-gastric cancer. Through a series of discussions and expert evaluations, a consensus was reached, which can be used for future research in clinical trials.

EUROPEAN JOURNAL OF CANCER (2023)

添加到收藏夹

Review Oncology

Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis

Tiuri E. Kroese et al.

Summary: Local treatment may improve overall survival in patients with esophagogastric cancer and oligometastatic disease (OMD). The current literature defines OMD as the presence of metastases limited to one organ with no more than three lesions and the presence of an extra-regional lymph node station. Local treatment appears to be associated with improved OS compared to systemic therapy alone.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

EA2183: A phase III study of consolidative radiotherapy in patients with oligometastatic HER2-negative esophageal and gastric adenocarcinoma.

Nataliya Volodymyrivna Uboha et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study

Tiuri E. Kroese et al.

Summary: This multicenter study assessed the incidence and survival of patients with esophagogastric cancer and oligometastatic disease (OMD) in two tertiary referral cancer centers in The Netherlands and Switzerland. The study found that local treatment plus systemic therapy was associated with improved overall survival compared to systemic therapy alone.

RADIOTHERAPY AND ONCOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma

Zhenguo Shi et al.

Summary: This study compared the efficacy of CCRT and chemotherapy alone in patients with SOESCC, showing that CCRT was associated with improved progression-free survival and overall survival. Decision tree models were able to accurately predict the risk stratification of patients.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Oncology

Local Ablative Treatment Improves Survival in ESCC Patients With Specific Metastases, 2010-2016: A Population-Based SEER Analysis

Hui Yang et al.

Summary: Our study found that metastatic esophageal squamous cell cancer (ESCC) patients may derive additional benefit from local ablative treatment (LAT) in addition to chemotherapy, particularly for patients with metastases other than bone/liver.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses

Zhenguo Shi et al.

Summary: This study evaluated the potential benefits of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma and established a nomogram for predicting survival outcomes. The results showed that CCRT was superior to chemotherapy alone in terms of treatment response and survival outcomes. The constructed nomogram effectively predicted individualized survival outcomes.

RADIOTHERAPY AND ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck et al.

Summary: The preoperative chemoradiotherapy regimen according to CROSS study has shown to have a long-term overall survival benefit for patients with locally advanced resectable esophageal or junctional cancer, with a stable effect observed up to 10 years of follow-up.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Otorhinolaryngology

Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes

Jeremy Chee et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

添加到收藏夹

Article Oncology

Short-Course 2-Dimensional Radiation Therapy in the Palliative Treatment of Esophageal Cancer in a Developing Country: A Phase II Study (Sharon Project)

Biniyam Tefera Deressa et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

添加到收藏夹

Article Oncology

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma et al.

LANCET (2019)

添加到收藏夹

Article Respiratory System

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases

Yongshun Chen et al.

JOURNAL OF THORACIC DISEASE (2019)

添加到收藏夹

Review Oncology

Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review

Francesco Sclafani et al.

JOURNAL OF SURGICAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer

Natasja R. Walterbos et al.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01)

Michael G. Penniment et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer

David M. Guttmann et al.

JOURNAL OF THORACIC ONCOLOGY (2017)

添加到收藏夹

Article Oncology

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI

Salah-Eddin Al-Batran et al.

BMC CANCER (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice

Thomas W. Rice et al.

ANNALS OF CARDIOTHORACIC SURGERY (2017)

添加到收藏夹

Review Oncology

Esophageal and Esophagogastric Junction Cancers

Jaffer A. Ajani et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.